[144] Okta, Inc. SEC Filing

Rhea-AI Filing Summary

Okta, Inc. filed a Rule 144 notice for a proposed sale of 10,000 common shares, with an aggregate market value of $916,900, and an approximate sale date of 10/02/2025. The shares were acquired as Restricted and Performance Stock Units on 03/15/2024 from the issuer and the filer reports 10,000 shares outstanding to be sold against a total of 168,459,019 shares. The filing also records a prior sale of 10,000 shares on 07/18/2025 under a 10b5-1 plan that generated $950,000 in gross proceeds. The notice includes the signature representation required by Rule 144 regarding possession of material nonpublic information.

Positive

• 10,000 shares were acquired as Restricted and Performance Stock Units on 03/15/2024
• A prior 10b5-1 sale of 10,000 shares on 07/18/2025 generated $950,000 in gross proceeds

Negative

• None.

Insights

Insider Transactions Analyst

TL;DR: Routine Rule 144 sale notice for 10,000 shares; prior 10b5-1 sale of 10,000 also disclosed.

This filing documents a proposed Rule 144 sale of 10,000 Okta common shares with an estimated market value of $916,900 and an expected sale date of 10/02/2025. The shares were acquired as Restricted and Performance Stock Units on 03/15/2024, and the filing lists a prior 10b5-1 sale of 10,000 shares on 07/18/2025 that produced $950,000 in gross proceeds.

The notice includes the standard representation that the selling party does not possess undisclosed material adverse information at the time of signing. Because this form is a required regulatory disclosure of planned sales, it is typically treated as a routine insider transaction record rather than an operational or financial disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	916900.00	168459019	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2024	Restricted and Performance Stock Units	Issuer			10000	03/15/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRETT TIGHE 100 First Street, Suite 600 San Francisco CA 94105	Common	07/18/2025	10000	950000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Okta's (OKTA) Form 144 disclose?

The Form 144 discloses a proposed sale of 10,000 Okta common shares with an aggregate market value of $916,900 and an approximate sale date of 10/02/2025.

Who acquired the shares being sold in the Okta filing?

The 10,000 shares were acquired as Restricted and Performance Stock Units from the issuer on 03/15/2024.

Does the Form 144 list prior sales by the seller?

Yes. The filing shows a prior 10b5-1 sale of 10,000 shares on 07/18/2025 that produced $950,000 in gross proceeds.

What is the total number of Okta shares outstanding noted in the filing?

The filing reports 168,459,019 shares outstanding for the issuer.

Who is identified as the seller in the past sale entry?

The past sale entry references BRETT TIGHE at the address provided for the 10b5-1 sales on 07/18/2025.